Dumasnskyi Yu. V., Lasachko P. S., Nikulin R. V.
Intra−arterial chemotherapy in treatment of head and neck cancer: 65 years of application. Any verdict?
51 - 56
Lisovyi V. M., Dubinina H. M., Khareba H. H., Shchukin D. V.
Health−dependent quality of life in patients with disseminated hormone−naive prostate cancer
57 - 62
Ragimzade S. E.
The features of reproductive function in women with breast cancer
63 - 66
Lisovyi V. M., Shchukin D. V., Harahatyi I. A., Khareba H. H., Poliakov M. M.
The overall results of surgical treatment of renal cell carcinoma with intravenous proliferation
48 - 54
Mikhanovskyi O. A., Kharchenko Yu. V., Kruhova I. M., Danyliuk S. V., Shchyt N. N., Fedorenko N. V., Teplova M. A.
Biomolecular markers as factors of prognosis of stage 3−4 ovarian cancer
55 - 58
Dubinina H. M.
Androgen deprivation therapy in combination with chemotherapy in patients with castrate−naive metastatic prostate cancer
59 - 64
Mikhanovskyi O. A., Kharchenko Yu. V., Dolgaia О. V., Krugova I. M., Fedorenko N. V., Shchit N. M., Teplova M. A.
Prospects of the use of molecular markers in cancer of ovaries
61 - 65
Basylaishvili S. Yu.
The effectiveness of adjuvant chemoradiotherapy in patients with non−small−cell lung cancer
65 - 68
Mikhanovsky A. A., Sukhina E. N.
Analysis of the efficacy of combination treatment of ovarian cancer patients with neoadjuvant chemotherapy
80 - 86
Voropay A. Yu.
Contemporary views on the problem of metastatic kidney cancer
87 - 89
Dumanskiy Yu. V., Basheev V. H., Ishenko R. V., Lasachko P. S.
Paraneoplastic syndrome in hepatocellular cancer
51 - 56
Bondar G. V., Dumansky Yu. V., Sidyuk A. V., Popovich A. Yu., Popovich Yu. A., Sidyuk E. E., Troyan P. P., Zaika A. N.
The variants of surgical treatment for esophageal cancer and gastric cancer involving the esophagus
57 - 60
Prokhach N. E., Gromakova I. A., Sorochan P. P., Ponomariov I. N., Gromakova I. S.
Pro−inflammatory cytokines and psychoneurological sings in cancer patients
95 - 101
Groma V. G., Frolov A. Yu., Oleynik A. E.
Morphological characteristics of perforated gastric cancer
102 - 104
Bondar G. V., Popovich A. Yu., Sidyuk A. V., Popovich Yu. A., Lisovskaya N. Yu., Sidyuk E. E.
Endolymphatic, intravenous and intra−arterial chemotherapy for metastatic inoperable gastric cancer
84 - 88
Popovskaya T. N., Vinnick Yu. A., Movchan A. V., Vinnick A. Yu.
Molecular genetic characteristics of sporadic gastric cancer
89 - 92
Derzhavets L. A.
Laboratory parameters as predictors of bladder tumor malignancy grade
93 - 99
Scherbina N. A., Kartashova M. A.
The use of hormone therapy at atypical endometria hyperplasia in patients with microsatellite instability and ESR gene methylation
82 - 86
Kudriashov A. G., Popovich A. Yu., Ostapenko Yu. V., Chistiakov R. S.
Treatment of patients with kidney cancer metastases to the lungs
87 - 89
Sorochan P. P., Gromakova I. S., Prokhach N. E., Gromakova I. A., Ivanenko M. O.
Melatonin administration in oncology
68 - 73
Vinnik Yu. A., Oleksenko V. V., Proniakov V. I., Efetova T. S., Zakharov V. A., Strokova E. V.
The peculiarities of fat uptake in patients with gastric cancer after gastrectomy depending on gastroplasty variant
74 - 79
Sidiuk A. V.
Intra−arterial chemotherapy in combination treatment for operable gastric cancer with metastases to the liver
81 - 84
Mikhanovsky A. A., Slobodianiuk O. V.
Contemporary aspects of diagnosis and treatment for ovarian cancer
85 - 89
Koliadko N. N., Dmitiryev V. V., Prokhorova V. I.
Assessment of functional activity of antithrombin III using the test of thrombin generation in cancer patients
89 - 93
Bondar G. V., Sidiuk A. V., Lisovskaya N. Yu., Popovich Yu. A., Khomutov E. V., Stashkevich M. A.
Urgent issues of chemotherapy for gastric cancer
79 - 83
Oleksenko V. V.
Quality of life of the patients with gastric cancer depending on the peculiarities of development and course of the disease
84 - 88
Sorochan P. P., Gromakova I. A., Prokhach N. E., Ponomariov I. N., Fedorenko N. V., Gromakova I. S.
The role of pro−inflammatory cytokines in anemia development in cancer patients
75 - 81
Vinnik Yu. A., Popovskaya T. N.
Combined treatment of the patients with colorectal cancer with metastases to the liver
43 - 47
Kartashov S. M., Gagua M. N.
Investigation of influence of GST gene methylation on the prognosis of ovarian cancer course
48 - 51
Starikov V. I., Belyi A. N., Khodak A. S., Slobodianiuk O. V.
Stem tumor cells: a new concept of carcinogenesis
90 - 94
Muzhichuk A. V., Afanasieva N. N.
The peculiarities of the clinical picture and treatment of thyroid microcarcinoma
94 - 98
Popovaskaya T. N., Vlasenko V. G.
Significance of molecular genetic investigations at breast cancer
79 - 82
Muzhichuk A. V., Afanasieva N. I., Muzhichuk V. V.
Early diagnosis of thyroid cancer in persons from the risk group
82 - 85
Muzhichuk A. V., Afanasieva N. I., Muzhichuk V. V.
Thyroid cancer prevention in the risk group
72 - 75
Muzhichuk A. V., Afanasieva N. I., Muzhichuk V. V.
The role of heredity in the course of differentiated thyroid cancer
93 - 97
Prokhach N. E., Sorochan P. P., Gromakova I. A., Moskalenko I. P.
The role of pro−inflammatory cytokines in development of behavioral disorders in cancer patients
98 - 102
Ivchenko A. L.
Individualization of therapeutic tactics in patients with ovarian cancer depending on the level of tissue kallikreins
103 - 105
Sorochan P. P., Gromakova I. A., Prokhach N. E.
Regulatory T−cells and new strategies of antitumor immune therapy
85 - 90
Muzhichuk A. V., Afanasieva N. I., Shevtsov V. G., Muzhichuk V. V.
Clinico−morphological characteristics of combined course of thyroid cancer and benign thyroid pathology
91 - 95
Starikov V. I.
Surgical aspects of combined treatment for cancer of the proximal portion of the stomach
92 - 96
Shcherbina O. V.
Methods of nuclear medicine in diagnosis and treatment of patients with prostate cancer
97 - 101
Muzhychuk A. V., Afanasieva N. I.
Therapeutic−diagnostic algorithm in focal thyropathy
76 - 81
Sakalo A. V., Scherbina O. V., Sakalo V. S.
Radiodiagnosis of regional metastases in germentative testicular tumors
82 - 85
Popovskaya T. N.
Modern ideas about the role of immune reactions in development of malignant tumors
124 - 127
Grigorenko V. N., Sakalo V. S., Scherbina O. V.
Modern approaches to monitoring the patients with prostate cancer
128 - 132
Starikov V. I.
Peculiarities of pathogenesis and treatment of dyshormonal hyperplasia and breast cancer
61 - 66
Scherbina O. V.
Methods of nuclear medicine in breast cancer treatment
67 - 75
Scherbina O. V., Moskalets A. I.
Radioimmunoassay of tumor markers in clinical practice
88 - 93
Gorbenko V. N.
The capabilities of ultrasonography and cytological diagnosis of extrathyroid cancer
94 - 97
Scherbina O. V.
The role of tumor markers in diagnosis of prostate gland cancer and the patient monitoring
89 - 95
Starikov V. I., Khodak A. S.
Detection of disseminated tumor cells in the blood, bone marrow and lymph nodes using molecular−biological methods
96 - 100
Gorbenko V. N., Ovsiannikova T. N., Nikitchenko Yu. V., Tishko T. V.
The contribution of membrane modification to thyroid cancer pathogenesis
101 - 104
Prokhach N. E., Sorochan P. P., Gromakova I. A.
Contemporary experience and prospects of immunomodulators application in complex therapy of cancer patients
86 - 93
Mikhanovsky A. A., Slobodianiuk O. V.
Modern aspects of multimodality treatment for uterine body cancer
94 - 98
Gorbenko V. N.
Free−radical processes as a specific factor of thyroid cancer development
99 - 102
Bondar G. V., Dumansky Yu. V., Sedakov I. E., Rogalev A. V.
Long−term results of complex treatment for metachronic breast cancer
110 - 113
Svinarenko A. V.
Comparative evaluation of pre− and post−operative radiation and chemoradiation therapy for rectal cancer
114 - 117
Dudnichenko A. S., Nazhett H. Haidar
Tumors with unrevealed primary focus: contemporary approaches to treatment
118 - 120
Bondar G. V., Popovich A. Yu., Lisovskaya N. Yu., Popovich Yu. A.
Contemporary capabilities of chemotherapy for lung cancer
82 - 86
Gnateyko O. Z., Kitsera N. I., Polischuk R. S.
Congenital development anomalies in sibs of children with acute leukemia
87 - 89
Starikov V. I.
Esophageal cancer: diagnosis and treatment prospects
66 - 70
Pereverzev A. S.
New clinical and diagnostic strategies in renal cancer
71 - 78
Orel V. E., Galakhin K. A., Korovin S. I., Dovgopolaya O. A., Morozov A. B., Romanov A. V., Dzyakovskaya N. N.
Chaos and malignant skin melanoma
87 - 93
Vorozhko A. G.
Rating of risk factors of rectal cancer relapses
94 - 96
Shponka I. S., Bondareva V. A., Gritsenko P. A.
The role of tissue markers in assessment of biological properties and prognosis of breast cancer
97 - 104
Popovskaya T. N.
Target therapy − a new direction of pharmaceutical treatment for malignant tumors
105 - 108
Starikov V. I.
Carcinoid tumors
90 - 92
Popovskaya T. N.
Immunotherapy: up−to−date standard of drug treatment for renal carcinoma
93 - 95
Otchenash N. N.
Contemporary methods of treatment for nonmelanoma skin cancer
96 - 98
Bilynsky B. T., Lukavetsky N. A.
Problems of cardioesophageal cancer surgery
124 - 126
Vinnik Yu. A., Neffa M. Yu., Kazmiruk O. V.
Contemporary views on ovarian cancer treatment
127 - 131
Perevodchikova N. I., Alekseyeva T. A.
Tumor pleurisy: diagnosis and choice of therapeutic tactics
88 - 93
Bondar G. B., Sedakov I. E., Smirnov V. N., Aliyeva S. O.
Evolution of methods of breast cancer treatment
94 - 98
Druzhina N. A., Chekhun V. F.
The problem of evaluation of low−dose radiation carcinogenic risk
78 - 82
Vinnik Yu. A., Yefimova G. S.
The use of Gemzar in chemoradiation treatment for non−small−cell lung cancer
83 - 86
Moskalenko I. P., Sukhina E. N., Tolkachev Yu. A., Nikiforova N. A., Sorochan P. P.
Circadian function and quality of life in patients with malignant tumors
87 - 91
Bondar G. V., Skochilias T. L., Sedakov I. E.
Hormone therapy for breast cancer
108 - 111
Prokhach N. E.
Immunotherapy in cancer treatment
112 - 116
Go on Top